等待开盘 02-10 09:30:00 美东时间
-0.335
-2.97%
FDA warns of high-risk device issue with wound and burn care products by Integra LifeSciences, citing infection risks.
01-24 01:22
Integra Lifesciences (NASDAQ:IART) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the pr...
2024-08-23 00:00
Citigroup analyst Joanne Wuensch maintains Integra Lifesciences (NASDAQ:IART) with a Sell and lowers the price target from $23 to $20.
2024-08-22 23:52